Muscle-Directed Gene Transfer and Transient Immune Suppression Result in Sustained Partial Correction of Canine Hemophilia B Caused by a Null Mutation [PDF]
Roland W. Herzog+4 more
openalex +1 more source
Thrombin Generation Assay to Support Hematologists in the Era of New Hemophilia Therapies
ABSTRACT Hematology laboratories have traditionally monitored hemophilia replacement therapy by measuring coagulation factors before and after infusion. However, new drugs that do not rely on the replacement of the deficient factor require new approaches to laboratory monitoring, as factor VIII (FVIII) or factor IX (FIX) assays are no longer adequate ...
Laurie Josset+2 more
wiley +1 more source
250. High Level Expression of Canine Factor IX in Hemophilia B Dogs after Readminstration of AAV2/5 Vectors [PDF]
openalex +1 more source
Gene Therapy Approaches for the Treatment of Hemophilia B. [PDF]
Soroka AB+3 more
europepmc +1 more source
Gene therapy for hemophilia B in dogs: finally prevention of bleeding, but concerns about inhibitors remain [PDF]
Katherine P. Ponder
openalex +1 more source
DNA variation in a 13-Mb region including the F9 gene: inferring the genealogical history and causal role of a hemophilia B mutation (IVS 5+13 A→G) [PDF]
Theodore Anagnostopoulos+4 more
openalex +1 more source
Massive Intramuscular Haematoma Due to Acquired Factor V Deficiency
eJHaem, Volume 6, Issue 2, April 2025.
Lara Budwig+5 more
wiley +1 more source
Descriptive Study of Hemophilia in Al-Ramadi City
Background: Hemophilia is hereditary bleeding distorted, and widespread in the world. The Objective: to identify the epidemiological characteristics of sample.
Ayyed Mohammed Namoos AL- Zubaidy
doaj
64. A Gene Deleted Adenoviral Vector Results in Phenotypic Correction of Canine Hemophilia B without Liver Toxicity or Thrombocytopenia [PDF]
openalex +1 more source